- Osmotica Pharmaceuticals (NASDAQ:OSMT) jumps 19% premarket, currently trading at $6.27 ahead of its arbaclofen PDUFA date which was set for December 29, 2020.
- On July 20, the company refiled marketing application seeking approval of arbaclofen extended-release tablets for the treatment of spasticity in multiple sclerosis patients.
- https://seekingalpha.com/news/3647508-osmotica-pharma-rises-19-ahead-of-expected-arbaclofen-pdufa-tomorrow
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.